Dina Attia (D Attia)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

South Asian journal of cancer

Abdominal radiology (New York)

Faculty of Medicine, Beni-suef University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Medicine, Beni-suef University

Egypt

MD, Professor and Chef of the Department :: Gastroenterology, Hepatology and Endemic Medicine

Publications

Yasser Fouad, Yasmine Gaber, Shereen Abdel Alem, Mohamed Abdallah, Sherief M Abd-Elsalam, Shaymaa Nafady, Dina Attia, Mohamed Eslam
Changes in the Etiologies of Liver Cancer in Upper Egypt over a Decade from 2010 to 2020: A Single Tertiary Care Center Study. South Asian journal of cancer 13 (1) (2023)
Yasser Fouad, Yasmine Gaber, Shereen Abdel Alem, Mohamed Abdallah, Sherief M Abd-Elsalam, Shaymaa Nafady, Dina Attia, Mohamed Eslam
Changes in the Etiologies of Liver Cancer in Upper Egypt over a Decade from 2010 to 2020: A Single Tertiary Care Center Study. South Asian journal of cancer 13 (1) (2023)
Dina Attia, Shereen Abdel Alem, Wafaa El-Akel, Wael Abdel-Razek, Mohamed Eslam, Yasser Mahrous Fouad, Imam Waked
Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis C virus infection-a population-based study. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
Taghreed M Farahat, Mehmet Ungan, Josep Vilaseca, Jacqueline Ponzo, Pramendra Prasad Gupta, Andrew D Schreiner, Wadeia Al Sharief, Kelly Casler, Tafat Abdelkader, Ludovico Abenavoli, Fatima-Zohra Mchich Alami, Mattias Ekstedt, Muntadar S Jabir, Matthew J Armstrong, Mona H Osman, Johannes Wiegand, Dina Attia, Veronique Verhoeven, Ashraf Abdul Qayoum Amir, Nagwa Hegazy Nashat, Emmanuel A Tsochatzis, Yasser Mahrous Fouad, Helena Cortez-Pinto
The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Dina Attia, Ahmed Gomaa, Shereen Abdel Alem
Letter to the editor: Pitfalls in the outcome differences between NAFLD and MAFLD. Hepatology (Baltimore, Md.) 76 (5) (2022)
Michelle Clayton, Núria Fabrellas, Jinkai Luo, Mohammed G Alghamdi, Azaa Hafez, Tahani Al Qadiri, Nevin Owise, Dina Attia
From NAFLD to MAFLD: Nurse and allied health perspective. Liver international : official journal of the International Association for the Study of the Liver 41 (4) (2021)
Dina Attia, Thomas Rodt, Steffen Marquardt, Jan Hinrichs, Bernhard C Meyer, Michael Gebel, Frank Wacker, Michael P Manns, Andrej Potthoff
Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdominal radiology (New York) 44 (3) (2020)
Yasser Mahrous Fouad, Reda Elwakil, Medhat Elsahhar, Ebada Said, Shamardan Bazeed, Ahmed Ali Gomaa, Almoutaz Hashim, Enas Kamal, Mai Mehrez, Dina Attia
The NAFLD-MAFLD debate: Eminence vs evidence. Liver international : official journal of the International Association for the Study of the Liver 41 (2) (2020)
Yasser Mahrous Fouad, Imam Waked, Steven Bollipo, Ahmed Gomaa, Yousef Ajlouni, Dina Attia
What's in a name? Renaming 'NAFLD' to 'MAFLD'. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Enas M Kamal, Mortada El-Shabrawi, Hisham El-Khayat, Naglaa M. Kamal, Yehia Sameh, Yasser Fouad, Dina Attia
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
H R El-Khayat, Enas M Kamal, M H El-Sayed, M El-Shabrawi, H Ayoub, A RizK, M Maher, R Y El Sheemy, Y M Fouad, Dina Attia
The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real-world experience. Alimentary pharmacology & therapeutics 47 (6) (2018)
Dina Attia, K El Saeed, W Elakel, T El Baz, A Omar, A Yosry, M H Elsayed, M Said, M El Raziky, M Anees, W Doss, Y El Shazly, Heiner Wedemeyer, G Esmat
The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients. Alimentary pharmacology & therapeutics 47 (9) (2018)

Dina Attia.css-eqlu8i{font-size:small;padding-left:4px;} (D Attia)

Publication Activity (10 Years)

Top Topics

Top Venues

Dina Attia (D Attia)